Cancer cell-derived exosome based dual-targeted drug delivery system for non-small cell lung cancer therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cancer cell-derived exosome based dual-targeted drug delivery system for non-small cell lung cancer therapy

Published:2024-12 Issue: Volume:244 Page:114141
ISSN:0927-7765
Container-title:Colloids and Surfaces B: Biointerfaces
language:en
Short-container-title:Colloids and Surfaces B: Biointerfaces

Author:

Wang Jun,Zhu Xinyi,Jiang Huijun,Ji Minghui,Wu Yuan,Chen Jin^ORCID

Publisher

Elsevier BV

Reference53 articles.

1. Lung cancer;Thai;Lancet,2021

2. Reprogramming of lipid metabolism in lung cancer: an overview with focus on EGFR-mutated non-small cell lung;Eltayeb;Cancer, Cells,2022

3. Durvalumab in NSCLC: latest evidence and clinical potential;Munoz-Unceta;Ther. Adv. Med Oncol.,2018

4. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA: A Cancer J. Clin.,2024

5. A genomically and clinically annotated patient-derived xenograft resource for preclinical research in non–small cell lung cancer;Woo;Cancer Res.,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP